Phenotyping Congenital Hyperinsulinism
Contact
Description
Eligibility and criteria
IRB Number:
19-015995
Eligible age range:
Clinical trial phase:
N/A
Official title:
What to expect
If you agree to take part, your participation will last for up to 6 days and will involve up to 6 study visits. First, you will have a 1-hour screening visit where we will confirm you are a good candidate for the study and we will ask you about your medical history to determine which of the following tests you are eligible for. Depending on your answers, we will then ask you complete some or all of the following phenotyping tests at our outpatient research facility:
- Blood draws
- Maximum 24-hour fasting test
- Oral protein tolerance test
- Oral glucose tolerance test
- Mixed meal tolerance test
- Physical exercise test
We need families like you
Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.